Biotecnika newspaper 6 march 2018

March 6th, 2018.

Vol. 02 NO 10

NEWS - PAGE 4 PRIME MINISTER’S RESEARCH FELLOWSHIP (PMRF) SCHEME – APPLICATIONS OPEN

NEWS - PAGE 6 A DAFFODIL ANTIDOTE TO CURE CANCER – LATEST DEVELOPMENT IN CANCER RESEARCH

PhD ADMISSIONS - PAGE 7

NEW JOBS AVAILABLE

PHD ADMISSIONS 2018 @ DR. RAM MANOHAR LOHIA AVADH UNIVERSITY, FAIZABAD

PAGES 11-12

Last Date to Apply & Eligibility

CSIR NET - JUNE 2018 NOTIFICATION

COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH HUMAN RESOURCE DEVELOPMENT GROUP, EXAMINATION UNIT CSIR COMPLEX, LIBRARY AVENUE, PUSA, NEW DELHI-110012.

NATIONAL ELIGIBILITY TEST (NET) Joint CSIR-UGC Test for Junior Research Fellowship and Eligibility for Lectureship Advertisement No.10-2(5)/2018(i) - E.U.II

By Diluxi Arya

CSIR NET – JUNE 2018 NOTIFICATION, LAST DATE TO APPLY & ELIGIBILITY Important Dates:

Notification Details: CSIR will hold the Joint CSIR-UGC Test Tentatively on Sunday 17th June, 2018 for determining the eligibility of the Indian

National candidates for the award of Junior Research Fellowships (JRF) NET and for determining eligibility for appointment of Lecturers (NET) in certain subject areas falling under the faculty of Science & Technology.

The award of Junior Research Fellowship (NET) to the successful eligible candidates will depend on their finding admission/placement in a university/ national laboratory/ institution of higher learning and research, as applicable.

1.1 A candidate may apply either for ‘JRF-Lectureship’ OR ‘JRF’ only OR ‘Lectureship (LS)’ only. He/she may indicate his/ her preference in the Online Application, as the case may be. CSIR may consider candidates for ‘JRF-Lectureship’ OR ‘JRF’ only OR ‘Lectureship (LS)’ only depending on number of fellowships available & performance in the test, subject to the condition that they fulfill the laid down eligibility criteria.

If a candidate is found to be over-age for JRF (NET) he/she will automatically be considered for Lectureship (NET) only. Candidates with M.Sc qualification OR under M.Sc Result Awaited (RA) category shall be eligible for LS subject to fulfilling the eligibility criteria as laid down by the UGC.

above Test. Candidates qualifying for JRF (NET), will also be eligible for Lectureship (NET) subject to fulfilling the eligibility criteria laid down by UGC. The candidates qualifying for Lectureship will be eligible for recruitment as Lecturers as well as for Junior Research Fellowship in a Scheme/Project, if otherwise suitable. However, they will not be eligible for Regular JRF-NET Fellowship.

Candidates qualifying for the award of JRF (NET) will receive fellowship either from CSIR or UGC as per their assignment or

Next Page>>>>

1.2 Two separate merit lists, one comprising of the candidates qualifying for the award of Junior Research Fellowship (JRF – NET) and the second, of those candidates qualifying the Eligibility Test for Lectureship (NET), will be made on the basis of their performance in the

GET THIS NEWSPAPER e-copy VIA WHATSAPP every week

GIVE MISSED CALL TO

080-395-34707 1

Vol. 02 NO 10

March 6th, 2018. from the Schemes with which they may find association. The candidates declared eligible for Junior Research Fellowship under UGC scheme and Lectureship will be governed by UGC rules/regulations in this regard.

3. DATE AND SCHEME OF THE TEST: The single paper MCQ based test will be held tentatively on Sunday, the 17th June, 2018 as under:

in the syllabus.

Part ‘C’ shall contain higher value questions that may test the candidate’s knowledge of scientific concepts and/or application of

Category:

1.3 The final result of this Single MCQ test may be declared sometime in the month of Sept/Oct., 2018 and fellowship to successful candidates will be effective from 1st January, 2019 with the validity period of 2 years for joining the fellowship under CSIR Scheme.

• • •

2.1 SUBJECTS OF THE TEST The Test will be held in the subjects as given under: 1. Chemical Sciences 2. Earth, Atmospheric, Ocean and Planetary Sciences 3. Life Sciences 4. Mathematical Sciences 5. Physical Science 2.2 EDUCATIONAL QUALIFICATION M.Sc or equivalent degree/ Integrated BS-MS/BS-4 years/BE/BTech/BPharma/ MBBS with at least 55% marks for General (UR) and OBC candidates and 50% for SC/ST, Persons with Disability (PwD) candidates.

Candidates enrolled for M.Sc or having completed 10+2+3 years of the above qualifying examination as on the closing date of online submission of application form, are also eligible to apply in the above subject under the Result Awaited (RA) category on the condition that they complete the qualifying degree with requisite percentage of marks within the validity period of two years to avail the fellowship from the effective date of award.

Such candidates will have to submit the attestation form duly certified by the Head of the Department/Institute from where the candidate is appearing or has appeared.

B.Sc(Hons) or equivalent degree holders or students enrolled in Integrated MSPhD program with at least 55% marks for General (UR) and OBC candidates; 50% marks for SC/ST, Persons with disability (PwD) candidates are also eligible to apply.

Candidates with bachelor’s degree will be eligible for CSIR fellowship only after getting registered/enrolled for PhD/Integrated PhD program within the validity period of two years.

Candidates having Bachelor’s degree only shall not be eligible for Lectureship.

Specification of degrees (whether Bachelor’s or Master’s) as notified by the UGC in its Gazette Notification No.F. 5-1/2013 (CPP-II) dt. 5th July, 2014 and as amended from time to time, shall apply.

The eligibility for lectureship of NET qualified candidates will be subject to fulfilling the criteria laid down by UGC. PhD degree holders who have passed Master’s degree prior to 19th September 1991, with at least 50% marks are eligible to apply for Lectureship only.

2.3 AGE LIMIT& RELAXATION: For JRF (NET):Maximum 28 years as on 01-01-2018 {upper age limit may be relaxed up to 5 years in case of SC/ST/Persons with Disability(PwD)/female applicants and 03 years in case of OBC(non creamy layer) applicants}.

For LS (NET): No upper age limit

2

following fee in cash through bank challan OR RTGS/NEFT through any bank (Bank account details are required to be filled in the Indian Bank challan form to be downloaded from online application system):-

Subject wise schedule of examination will be notified later on. The subject-wise Schedule, date and timing of the Test is liable to be changed at the discretion of CSIR. To enable the candidates to go through the instructions printed on the OMR Answer Sheets and also to correctly fill up the required particulars in the said OMR Answer Sheet, the same will be distributed 15 minutes before the schedule time of start of the examination. The Test Booklet shall be distributed 5 minutes before the scheduled time of the exam & candidates are permitted to take duplicate copy of their OMR Answer Sheet while leaving the exam venue. The actual number of questions in each part and section to be asked & attempted may vary from subject to subject.

The candidates will not be permitted to leave the examination hall before the expiry of 3 hrs. from the start of the exam (i.e not before 12.00 noon in the morning session/5.00 PM in the afternoon session).

These candidates are permitted to take their Test Booklet with them at the end of the scheduled time of exam.

Candidates should use only black ball point pen to fill in their particulars in the OMR Answer Sheet/Test Booklet and also to darken the appropriate circle to mark their answers in their OMR answer sheet.

Candidates are not permitted to erase, scratch out, overwrite or use whitener fluid/eraser fluid to change their answers in the OMR sheet; otherwise that particular answer will not be evaluated.

The Test Booklet for this test will be printed in Hindi & English Version. The candidates opting for Hindi medium in the Application Form, will be given bilingual Test Booklet and Candidates opting for English medium will be given Test Booklet printed in English Version only. The candidate will be required to answer as per option exercised in the application Form.

3.1 SYLLABUS OF THE TEST The Test Booklet shall be divided into three parts, (A, B & C) as per syllabus & Scheme of Exam.

Part ‘A’ shall be common to all subjects.

This part shall contain questions pertaining to General Aptitude with emphasis on logical reasoning, graphical analysis, analytical and numerical ability, quantitative comparison, series formation, puzzles etc Part ‘B‘ shall contain subject-related conventional Multiple Choice questions (MCQs), generally covering the topics given

the scientific concepts. The questions shall be of analytical nature where a candidate is expected to apply the scientific knowledge to arrive at the solution to the given scientific problem.

Syllabus & Scheme of Exam of single MCQ Paper may be seen at CSIR HRDG website: www.csirhrdg.res.in. Note: The Exam Scheme for Chemical Sciences has been revised from June, 2017 CSIR-UGC (NET) Exam onwards. The revised exam scheme and model Question paper may be seen at CSIR HRDG website www. csirhrdg.res.in 3.2 Negative marking for wrong answers, wherever required, shall be applicable as per subject wise scheme of Exam.

3.3 If a question for any reason found wrong, the benefit of marks will be given to only those candidates who attempt the question.

3.4 No grievances/representation with regard to Answer Key(s) after declaration of result will be entertained 4. EXAMINATION CENTRES The test will be held at 27 Centres spread all over India, as specified below: Bangalore, Bhavnagar, Bhopal, Bhubaneshwar, Chandigarh, Chennai, Cochin, Delhi, Guntur, Guwahati, Hyderabad, Imphal, Jammu, Jamshedpur, Jorhat, Karaikudi, Kolkata, Lucknow, Nagpur, Pilani, Pune, Raipur, Roorkee, Srinagar, Thiruvananthapuram, Udaipur and Varanasi.

A candidate may opt for any of the above centres. No request for change of centre would ordinarily be granted. However, a request in writing for change of Centre may be entertained on merits, if received in this unit latest by 20.10.2017. If sufficient number of candidates do not opt for any of the above Centres, that particular Centre may stand deleted from the above list OR otherwise also, the concerned candidates may be allotted another Centre nearest to their place of residence, at the discretion of CSIR. No TA/DA will be admissible to any candidate for attending the test, in any circumstances.

5. HOW TO APPLY: 5.1 Examination Fee: Candidates applying for the Test may deposit their Examination fee, after verifying their eligibility, in any branch of the Indian Bank throughout the country by paying the

General - Rs.1000/-(Fee) Other Backward Classes(OBC) - Non Creamy Layer - Rs.500/-(Fee) SC/St/Persons with Disability(PwD) Rs.250/-(Fee)

OBC candidates whose caste is not listed in Central List (as available on National Commission for Backward Classes website www.ncbc.nic.in) and who are not covered under the provisions as applicable to OBC – Non Creamy Layer (NCL) candidates, shall be treated as General Category candidates for all purposes. Accordingly, OBC Candidates not belonging to OBC Non Creamy Layer shall indicate their category as ‘General’.

5.2 APPLY ONLINE: Before applying Online, candidates are advised to go through the detailed notification available at CSIR, HRDG website CAREFULLY. Candidates must write their name, father/ mother’s name as written in their Matriculation Certificate (X Class Board) and should ensure that the same are matching with their educational qualification certificates and caste certificate except for married females. Successful married female candidates are required to send scanned copy of their marriage certificates alongwith any other documents as proof as may be required by CSIR-HRDG, through e-mail to : mailnetquery@gmail.com. All Caste/PwD Certificates shall be strictly as per Govt. of India instructions. The validity of OBC certificates (Non-creamy layer) shall be governed as per Govt. of India instructions.

After filling the online application, candidates should preview their entire application form and make changes if required before final submission of online application. No change in the particulars entered in the application form will be possible after final submission of online application and no correspondence in this regard will be entertained. In the event of qualifying the JRF/LS NET exam, certificate will be issued strictly on the basis of information provided by the candidate in his/her online application form.

After successful submission of ONLINE Application, an Application Number will be auto-generated. The candidates are advised to preserve the Application Number for future reference and for downloading his/her e-Admit Card. The candidate should also keep a print (hardcopy) of the duly filled-in application form for future use. The candidate is also advised to note down his/her e-mail ID and Password for future reference.

A candidate should submit only one application. If a candidate submits more than one application, none of the applications of such candidate will be entertained.

Examination fee paid will neither be adjusted for any subsequent examination nor refunded under any circumstances.

Next Page>>>>

Vol. 02 NO 10 IN ORDER TO AVOID LAST MINUTES RUSH, THE CANDIDATES ARE ADVISED TO APPLY EARLY ENOUGH. CSIR WILL NOT BE RESPONSIBLE FOR NETWORK PROBLEM OR ANY OTHER SUCH TYPE OF PROBLEM. 5.3. CANDIDATE SEEKING FEE CONCESSION The candidate should upload an attested copy of his/her category certificate as a proof of his/her claim. An application form , claiming any concession in fee, age & educational qualification but without an attested copy of a valid SC/ST/OBC (NCL)/PwD (40% or more disability certificate from a competent authority and in prescribed format), will be summarily rejected. OBC candidates, who are not covered vide the provision of Non Creamy Layer (NCL) as per the provisions of Govt. of India shall not be eligible to get the benefit of relaxation in age, fee concession etc.

Candidate must note that for availing OBC category benefit CSIR follows only Central Govt. list and not the State Govt. lists. Similarly, candidate applying under PwD category may note that Govt. of India rules will be applicable in this regard, otherwise they shall not be eligible for any concession.

5.4. PROVISION FOR PERSONS WITH DISABILITY (INCLUDING VISUALLY CHALLENGED CANDIDATES) HAVING 40% OR MORE DISABILITY. (i) Candidates with disabilities having 40% or more disability in upper limbs, visual impairment, low vision, cerebral palsy who have physical limitation to write with that of speed, if they request for scribe in their online application, will be provided the services of a scribe from our panel of scribes. The candidate is allowed to meet the scribe one or two days before the examination so as to verify whether the scribe is suitable or not, after getting confirmation from the respective Centre Coordinator. (ii) Such candidate has the discretion of opting for his/her own scribe at his/her own cost.

The candidate should send a written request for bringing his/her own scribe to the centre Coordinator concerned at least two days before the examination. (iii) PwD candidates will also be given compensatory time of 60 minutes in addition to the 3 hours duration of the Exam. (iv) On prior request, at least three weeks before the examination, visually challenged candidates will be provided Test Booklet in large font as per the medium of exam opted by the candidate in his/her online application.

6. THE LAST DATE FOR SUBMISSION OF ONLINE APPLICATION FORM WILL BE 26.03.2018 Candidates should note carefully that submission of examination fee will be only through Credit Card, Debit Card or NET Banking.

Candidates should also note carefully that the online application form has provision for uploading the following certificates/documents: 1). Scanned photograph (JPEG/JPG format with dimension ranging from 130×160 to 260×360. File size should be less than 150KB; valid file name; should have only one extension. Only Alpha-Numeric characters allowed with hyphen (-) and underscore (_). Space not allowed);

March 6th, 2018.

2). Scanned Signature (JPEG/JPG format with dimension ranging from 90×25 to 225×100. File size should be less than 150KB; valid file name; should have only one extension. Only Alpha-Numeric characters allowed with hyphen (-) and underscore (_). Space not allowed); 3). Qualifying Degree Certificate or last semester marksheet or testimonials clearly mentioning the semester that you are pursuing or passed with clear indication of % of mark scored, to confirm your eligibility to take the exam. The candidates are to note that the uploaded document should clearly indicate the % of mark scored. (PDF format; File size should be less than 400KB; valid file name; should have only one extension. Only Alpha-Numeric characters allowed with hyphen (-) and underscore (_). Space not allowed); 4). Category certificate that you belong to SC/ST/PwD/OBC (non-creamy layer) (PDF format; File size should be less than 400KB; valid file name; should have only one extension. Only Alpha-Numeric characters allowed with hyphen (-) and underscore (_).

Space not allowed); 5). PwD Certificate (PDF format; File size should be less than 400KB; valid file name; should have only one extension. Only Alpha-Numeric characters allowed with hyphen (-) and underscore (_). Space not allowed); 6). Candidates applying under Result Awaited (RA) category should upload the Attestation Form duly attested by the HoD of the University/College/Institute (PDF format; File size should be less than 400KB; valid file name; should have only one extension. Only Alpha-Numeric characters allowed with hyphen (-) and underscore (_).

Space not allowed).

These certificates/documents are essential to verify your eligibility for the exam on the basis of your educational qualification, % of mark etc. and also for age relaxation and fee concession.

As candidates are not required to send hard copies of application alongwith requisite certificates/documents for this Exam, candidates should, therefore, make sure that they upload all the relevant certificates/documents so as to avoid disqualification for want of the requisite certificates/documents.

The candidates are advised in their own interest to apply early 7. IMPORTANT POINTS: 1. While applying for this test, please ensure that you fulfill all the eligibility conditions and follow all the laid down procedures/ guidelines for this test.

2. While applying Online, apply early enough to avoid any last minute rush.

3. List of candidates registered for this test will be made available on our website tentatively on 18.05.2018. The candidates must refer to our website for checking their registration in time & for updates from time to time.

4. Facility for downloading e-Admit Cards to the registered candidates will be provided on our website www.csirhrdg. res.in. No paper Admit Card will be sent by post. No duplicate e-admit card shall be issued to the candidates at the Exam Centre. CSIR will not be responsible for any delay on the part of the candidates.

5. The Test Booklet for this test will be printed in Hindi & English Version. The candidate opting for Hindi medium in the Application Form, will be supplied bilingual Test

Booklet and Candidate opting for English medium will be supplied Test Booklet printed in English Version only. The candidate will be required to answer as per option exercised in the application Form.

6. The actual number of questions in each Part and Section to be asked and attempted may vary from subject to subject.

7. Candidates enrolled for M.Sc or having completed 10+2+3 years of the required qualifying Exam may apply under Result Awaited (RA) category & upload attestation form.

8. A candidate should not submit more than one application. If a candidate submits more than one application none of the applications of such candidate will be entertained.

9. Candidate should exercise due care in filling up the application form. In case of any error on the part of the candidate, he/she will be held solely responsible for any loss suffered by him/her. No change in the entries made in the original application form will be allowed under any circumstances at later stage.

10. No candidate shall be permitted to leave the Exam Hall before the expiry of 3 Hours from the start of the exam.

11. The candidates will be permitted to take their Test Booklet and also the carbonless duplicate copy of OMR sheet with them after the completion of the examination for their reference/record.

12. The OMR Answer Sheets shall be distributed to the candidates 15 minutes before the scheduled start of the exam while the Test Booklet shall be distributed 5 minutes before the scheduled start of the exam to enable the candidates to go through the instructions and correctly fill up the required particulars.

13. No individual intimation by any mode will be sent to the candidates 14. OBC candidates whose caste is not listed in Central List (as available on NCBC website) and are not covered under the provisions as applicable to OBC Non Creamy Layer (NCL) shall be treated as a General Category candidates for all purposes and shall not be eligible to get the benefit of relaxation in age & fee concession etc. Accordingly, OBC Candidates not belonging to OBC Non Creamy Layer shall indicate their category as ‘General’.

is strictly provisional till their joining. (vi) Please note that no correspondence will be entertained for any matter for which last date has expired. (vii) In all matters the decision of the CSIR as to the eligibility or otherwise of a candidate for admission to the Test or his/her subsequent qualifying in the Test shall be final. (viii) Any attempt on the part of a candidate to obtain support for his / her candidature by any means may disqualify him/her for admission to the examination. (ix) A candidate who is found guilty of impersonation or of submitting fabricated documents or documents which have been tampered with or of making statements which are incorrect or false or of suppressing material information or otherwise resorting to any other irregular or improper means for obtaining admission to the examination, or of using or attempting to use unfair means or abscond with OMR Answer sheet/Test booklet unauthorisedly or of misbehavior in the examination hall, may, in addition to rendering himself liable to criminal prosecution (a) be debarred by the CSIR from this test and future tests also (b) will be liable to disciplinary action under the appropriate rules, if he/ she is already in service under Government/ Autonomous Bodies/UGC/CSIR. (x) All disputes pertaining to the NET Examination shall fall within the jurisdiction of Delhi only. (xi) CSIR will not be responsible for any printing error in this Advertisement.

8. OTHER GENERAL INFORMATION: (i) The candidates are advised to go through this notification and our future notification(s) including terms & conditions given/uploaded on our website for this test. The candidate must satisfy themselves regarding their eligibility for this test before applying for this test. (ii) Candidates must read the terms and conditions for CSIR /UGC Research Fellowships/LS on the respective websites. (iii) The Center and date of the Test are liable to be changed at the discretion of CSIR. No TA/DA will be paid to the candidates by the CSIR. (iv) No candidate will be admitted to the Test unless he/she holds the e-Admit Card to the Test. The mere fact that an e-Admit Card has been issued to a candidate will not imply that the Council has finally accepted his/her candidature. Candidates e-Admit Card particulars/photo and signature should tally with the actual candidate who is to appear in the exam, otherwise he/she shall not be allowed to appear in the exam. (v) Candidates may note that the verification of essential eligibility conditions of a candidate with reference to the documents uploaded will be taken up only by the Lecturer appointing/JRF awarding authorities after the candidate has qualified in the Test. The candidate should note that their candidature

3

Vol. 02 NO 10

March 6th, 2018.

Prime Minister’s Research Fellowship (PMRF) Scheme – Applications Open Prime Minister’s Research Fellowship (PMRF) scheme has been promoting research & Cutting edge technologies. Prime Minister’s Research Fellowship Scheme has been designed for candidates who are willing to do Doctoral Studies (Ph.D.) in IITs and IISc, it aims at attracting the best talent in the country. Applications are open for Prime Minister’s Research Fellowship (PMRF) Scheme 24 February 2018 and the deadline for application is 31 March 2018.

About Prime Minister’s Research Fellowship (PMRF) Scheme The Prime Minister’s Research Fellowship (PMRF) scheme is aimed at attracting the talent pool of the country to doctoral (Ph.D.) programs of Indian Institutes of Technology (IITs) and Indian Institute of Science (IISc) for carrying out research in cutting edge science and technology domains, with focus on national priorities.

Under the PMRF scheme, students who have completed, or are pursuing, the final year of four year undergraduate or five year integrated M.Tech or five year integrated M.Sc. or five year undergraduate-postgraduate dual degree programs in Science and Technology streams from IISc/IITs/NITs/ IISERs and centrally funded IIITs are eligible for admission to full time Ph.D. programme in the IITs & IISc provided they fulfil prescribed eligibility criteria and finally get selected after shortlisting/written test/interview.

For each participating IIT and IISc the Ph.D admissions under the PMRF scheme will be supernumerary.

Applicants who fulfill the eligibility criteria, and are finally selected through a selection process, will be offered admission to Ph.D. program in one of IITs/IISc with a fellowship of Rs.70,000/- per month for the first two years, Rs.75,000/- per month for the 3rd year, and Rs.80,000/- per month in the 4th and 5th years. Apart from this, a research grant of Rs.2.00 lakh per year will be provided to each of the Fellows for a period of 5 years to cover their academic contingency expenses and for foreign/national travel expenses.

There will be a rigorous review of the performance of Prime Minister’s Research Fellowship holders and continuation of the next year fellowship shall be contingent upon successful review.

Apart from this, each Fellow would be eligible for a research grant of Rs. 2 lakhs per year (total Rs. 10 lakh)

The tenure of fellowship will be four years for students from integrated courses and five years for B. Tech. students.

Industry participation in the PMRF programme would be explored through CSR funding so as to enable industry to sponsor maximum number of fellows.

Eligibility For Prime Minister’s Research Fellowship (PMRF) Scheme : The applicants for the PMRF should: • have completed or be pursuing the final year of four (or five) year undergraduate or five year integrated M.Tech or five year integrated M.Sc. or five year undergraduate-postgraduate dual degree programs in Science and Technology streams from IISc/ IITs/NITs/IISERs and centrally funded IIITs; • have secured at least CGPA/CPI of 8.0 (in scale of 10.0). For applicants in five year integrated or dual degree programs if separate CGPAs/CPIs are awarded for UG and PG parts of the program then the CGPA/CPI of UG part (first four year) will be considered.

• have completed the required academic qualification in the last five years.

Merely satisfying the eligibility requirement does not guarantee admission. Final selection for admission of applicants will be done following a rigorous selection process.

Abstract Submission •

•

• •

The Project abstract should clearly articulate the area of the study and should display keen interest and insight on the subject chosen.

The Project abstract should formulate a problem for the study which would be used for assessing the applicant’s analytical and research skills.

The topic chosen shall be preferably in cutting-edge technology and science, with focus on national priorities.

The abstract should be original in applicant’s own words, provide formulation and other technical details of the problem. Evaluation of the abstracts will be an important component in the final selection of applicants for the PMRF.

Broad Disciplines & Nodal Institutes Admission under the PMRF will be made in 18 broad disciplines.

For each broad discipline one IIT or IISc will coordinate the admission process (review applications, shortlist applicants, constitute selection committees and hold final selections) and will be referred to as the Nodal Institute for that broad discipline.

Selection Process •

•

The shortlisting and selection will be done in the following manner: •

• •

Each nodal institute will have a team of experts who will assess the applications and prepare a shortlist of applicants for written test and/or interview at the nodal institute.

Shortlisted applicants will be called for a written and/or interview at the nodal institute.

Final selection of shortlisted applicants will be made based on the performance in the interview

Intellectual Property Rights (IPR) The IPR policy shall be as per the Institute’s Policy on IPRs. The IPRs are owned by the Institution where the Fellow has worked.

Monitoring Mechanism •

• • •

4

The selection process for the PMRF will be a rigorous two stage process with screening by the Reviewers and final selection by the Selection Committee for each broad discipline to ensure selection of the best talent.

An applicant may apply for more than one combination of broad discipline and institute. An applicant will be required to provide preferences in case the applicant wishes to apply for more than one combination of discipline and institute.

The National Coordination Committee (NCC) will periodically review and monitor implementation of the scheme.

The NCC will report to MHRD the status of the scheme, fund flow and utilization thereof, and policy changes required to make the scheme more effective.

Apart from this, the monitoring will be done in the manner detailed below: There will be internal reviews twice a year.

There will be a National Convention every year where all PMRFs will showcase their work. This will be an occasion for the Industry to participate in the Convention.

•

There will be a website set up by the NCC showcasing the areas of work of each PMR.

Important dates: • • • •

Commencement of submission of applications: 24 February 2018 Deadline for submission of the applications: 31 March 2018 Tentative dates for interviews at Nodal institutions: 15 May 2018 onwards Tentative date for announcement of results: 01 June 2018

PMRF Participating Institutions : IISc Bangalore IIT Bhilai IIT BHU IIT Bhubaneswar IIT Bombay IIT Delhi IIT Dharwad IIT(ISM) Dhanbad IIT Gandhinagar IIT Goa IIT Guwahati IIT Hyderabad IIT Indore IIT Jodhpur IIT Kanpur IIT Kharagpur IIT Madras IIT Mandi IIT Patna IIT Roorkee IIT Ropar IIT Jammu IIT Palakkad IIT Tirupati Having Doubts about Prime Minister Research Fellowship Scheme , find out your answers below : 1. Q. Which students are eligible to apply for the PMRF scheme?

A. The final year students and those who are awarded degree in past five years, of four year undergraduate or five year integrated M.Tech. or integrated M.Sc. program from IISc/IITs/NITs/IISERs/centrally funded IIITs are eligible.

B.Des. admitted through JEE/UCEED and 4-year BS or B.Sc students of IISc, IITs, or IISERs admitted through JEE,

Next Page>>>>

Vol. 02 NO 10 KVPY, and SCB are also eligible.

2. Q. I completed my B.Tech. degree three years ago from an NIT/IIT. Am I eligible to apply for PMRF? A. Yes. Those who are awarded degree in past five years (i.e. graduated during or after 2014) are eligible to apply for PMRF 2018.

Each application will be treated as a fresh application.

3. Q. I am a final year student of BS program in an IISER. I joined my course through KVPY. Am I eligible for PMRF? A. Yes. The final year students (and those who are awarded degree in past five years) of four year undergraduate or five year integrated M.Tech. or integrated M.Sc. program from IISc/IITs/NITs/IISERs/centrally funded IIITs are eligible. B.Des. admitted through JEE/ UCEED and 4-year BS or B.Sc students of IISc, IITs, or IISERs admitted through JEE, KVPY, and SCB are also eligible.

4. Q. I completed my B.Tech. from a college not included in the list of qualifying institutes above and thereafter obtained M.Tech. from an IIT. Am I eligible to apply?

A. No. The qualifying degree (i.e., four year undergraduate or five year integrated M.Tech or five year integrated M.Sc. or five year undergraduate-postgraduate dual degree program in Science and Technology streams) must be from IISc or an IIT/NIT/IISER or a centrally funded IIIT. 5. Q. I am a dual degree student at an IIT. I have been awarded two separate CGPAs for my B.Tech. and M.Tech. degrees. Which CGPA will be considered as qualifier?

A. The CGPA/ CPI of B.Tech. shall be considered as the eligibility criteria for the applicants with dual degrees (B.Tech. + M.Tech.) where two separate CGPA/CPI for B.Tech. and M.Tech. are provided. If a combined CGPA / CPI is given, then the combined CGPA will be considered.

6. Q. My CGPA until seventh semester is 8.19, however, I have a backlog. Am I eligible to apply?

A. No. 7. Q. I am a final year student and have <8 CGPA until seventh semester. Should I be provisionally allowed to appear for the selection procedure subject to the condition that I will improve my CGPA at the end of my B.Tech?

A. No. You will not be considered this year for the selection procedure. However, you

March 6th, 2018. may apply for the PMRF next year should you secure CGPA of 8 or more at the time of graduation.

8. Q. I am a PhD scholar in an IIT/IISc. I graduated from NIT and joined IIT under the Direct PhD programme. Whether existing scholars like me who meet all the criteria, but have joined last year will be eligible to upgrade to PMRF? A. No. You will have to apply afresh and if selected and allocated the same institute where you are currently registered for Ph.D. program, you will be eligible for PMRF for the rest of the PhD tenure. For example, if you have availed MHRD fellowship for two years, you will be entitled for maximum three years of PMRF, total five years.

Application 9. Q. Which are the institutes where PMRF Fellows can join to undertake research work as a Ph.D. student?

A. The institutes are the 23 IITs and IISc. 10. Q. I have interests in two disciplines, chemistry and nanotechnology. Can I apply for more than one discipline?

A. Yes. An applicant can apply for multiple disciplines. She / he will need to individually appear for multiple written tests and/or interviewsconducted at the respective nodal institute.

11. Q. Do I need to submit a project proposal along with my application?

A. You must submit an abstract as described on the PMRF website.

12. Q. Does PMRF scheme apply for parttime Ph.D.?

A. No, PMRF is for undertaking full-time Ph.D. program at IITs/IISc. 13. Q. Is there a word limit for the abstract?

Can I upload the proposal in JPEG format?

A. The word limit is 1000 and it must be in PDF format. No other format is acceptable.

14. Q. What is expected from the project abstract?

A. The requirement for a project abstract is aimed at assisting the selection committee to judge research and analytical capability of the applicant. The originality of the abstract is very important. The abstract will be checked for plagiarism.

A. The referees should be from among those with whom the applicant has closely interacted during her or his undergraduate or post- graduate programme and who can comment on the applicantâ&#x20AC;&#x2122;s academic knowledge and research and analytical skills.

16. Q. How many times can I apply for fellowship under the PMRF scheme?

A. You can apply two times provided all eligibility criteria are met each time.

17. Q. If I am selected for fellowship under the PMRF scheme this year, but do not avail the offer, can I apply once again next year?

A. No. However, you can defer your admission for one year subject to approval of the host institute.

18. Q. Is the PMRF scheme the same as the CII-PMF scheme?

A. No, they are different.

Written test and interview 19. Q. What will be the syllabus for the written test?

A. The syllabus for the written test will be the same as that of GATE/JAM/CEED, as applicable.

Preference, allocation of seats 24. Q. How will be the institute and discipline be allotted to the selected applicant if the applicant has selected more than one institute?

A. The applicant will be allotted a combination of institute and discipline as per the ranking order after the interview round. If an applicant is selected for more than one combination of discipline and institute, the combination will be allotted based on the preference indicated by the applicant in the application.

25. Q. Can I give preference for different disciplines in an IIT/IISc? A. Yes. An applicant is asked to give preference in form of combinations (e.g. Chemistry at IISc, Biochemistry at IIT Bombay, Nanotechnology at IIT Delhi, etc.).

26. Q. I have a specific idea for my potential research topic. Will the selection committee consider this while allocating me an institute/ discipline if I am selected?

A. The applicant may give her/his preference for the discipline/institute where the research of her/his specific interest is conducted.

Fee Payment:

20. Q. Where will the test centres be located?

27. Q. Is there an application fee, and if yes how can I pay the application fee?

A. A single written test and/or interview for each broad discipline will be conducted at the IIT or IISc which is the Nodal Institute for that broad discipline.

A. Yes, there is an application fee of Rs 1000. The applicant should click on the fee payment link that will connect to SBI Collect. The applicant does not need to have an SBI account to pay the fees on the SBI Collect page. The fee can be paid through various modes that include net banking, debit, and credit card etc. The applicant will need to enter the SBICollect Reference Number and upload the SBICollect e-receipt pdf file for the online application.

21. Q. Will the written test/ interview of different streams be conducted on the same date.

A. No. The tests will be conducted on different dates with a gap of a day or two so that an applicant may reach from one Nodal Institute to the other Nodal Institute in time.

22. Q. Will there be any TA/DA provided for appearing for the test or interview?

A. No TA/DA will be provided to applicant appearing for the written test or interview.

23. Q. Will all the eligible applicants be called for the written test and/or interview?

A. Not necessary. In case of a large number of applicants, only shortlisted applicants will be called for the written test and/or interview.

Contact Us Coordinating institute: INDIAN INSTITUTE OF TECHNOLOGY, HYDERABAD Address: Indian Institute of Technology Hyderabad Kandi, Sangareddy â&#x20AC;&#x201C; 502285 Telangana, INDIA Email (for application related support): support@pmrf2018.iith.ac.in Tel.: 040 23017112

15. Q. Who can be the referees?

5

Vol. 02 NO 10

March 6th, 2018.

A Daffodil Antidote to Cure Cancer – Latest Development in Cancer Research Flower power to shield us all from cancer?

Likely- a new finding describes the anti-cancer effects of a natural alkaloid extracted from Daffodils.

Researchers at the Université libre de Bruxelles (ULB) in Belgium led by Denis Lafontaine extracted an alkaloid, haemanthamine, which is capable of binding to ribosomes, the nanomachines that cancer relies on to synthesize proteins.

Ribosomes are a complicated of molecules present in all cells, known as nanomachines, they synthesize the entire proteins our cells want. Since tumors are necessarily simply cells which might be rising out of keep watch over, they may be able to hijack ribosomes to ramp up protein manufacturing.

But this mechanism may also be most can-

cers’s weak point. After extracting haemanthamine from daffodils, the ULB researchers discovered that the compound attacked most cancers in numerous tactics without delay.

First, it stopped ribosomes from generating proteins, which bogged down the expansion of the tumor.

Further up the road, it even stopped ribosomes themselves from being produced. Not best does that still gradual the most cancers’s expansion, however it triggers a tension reaction in an anti-tumor surveillance pathway.

A protein referred to as p53, which in most cases is frequently degrading away in wholesome cells, is stabilized, inflicting a fast mobile dying.

This study provides for the first time a molecular explanation to the anti-tumoral ac-

Photo-Assisted Nanoscale Gold for a Smarter Drug Delivery System The development of a wide spectrum of nanoscale technologies is beginning to change the scientific landscape in terms of disease diagnosis, treatment, and prevention. The surge in nanomedicine research during the past few decades is now translating into considerable commercialization efforts around the globe, with many products on the market and a growing number in the pipeline.

In this direction, scientists at the Technion-Israel Institute of Technology, have now designed a unique polymer coating that contains nanoscale gold particles which also has a drug embedded and can deliver the drug to the targeted region. The drug only releases when a light shines on the gold particles, causing the polymeric coating to melt.

“Photo-triggered materials fulfill a vital role in a range of bio-medical applications,” said Doctoral candidate Alona Shagan. “But despite this enormous potential, these materials are rarely used because of toxins in the polymer coating itself, and damage caused by high-energy (shortwave) light.”

The team developed the one-of-a-kind delivery method to release under longwave

light (Near-Infrared, NIR). The light warms the gold nanoshells, melting the polymer packaging, and releasing the drug. The primary advantage of NIR light is its ability to penetrate bodily tissues without harming them.

“We’ve developed a material with varying melting points, allowing us to control it using low intensities,” explains Prof. Boaz Mizrahi. “Our system is composed of FDA-approved materials, and we are relatively close to clinical application.”

The researchers believe this new technology can be used for a variety of other applications, such as sealing of internal and external injuries, temporary holding of tissue during surgery, or as biodegradable scaffolds for growing transplant organs. It may even be possible to use the polymer as part of the self-healing process, giving it a wide range of both medical and non-medical applications.

The next step will include creating particles that include the drugs so that we can test their improved effectiveness using this delivery technology, say the researchers.

By Disha Padmanabha

6

By Disha Padmanabha

tivity of Daffodils used for centuries in folk medicine. In a near future, the team in collaboration with Veronique Mathieu (Faculty of Pharmacy- ULB), will test the effect on ribosome biogenesis and function of four Amaryllidaceae alkaloids, representative of

the chemical diversity of these molecules.

Their goal will be to identify rapidly the most promising chemical backbone to be further developed as a lead compound in cancer therapeutics.

A NEW THERAPEUTIC APPROACH FOR BRAIN CANCER THROUGH ZIKA? First identified in Uganda in 1947, the Zika infection is a mosquito-borne disease which for most people, is a very mild infection and isn’t harmful. However, it may be more serious for pregnant women, as there’s evidence it causes birth defects – in particular, abnormally small heads (microcephaly).

However, a recent study shows that the virus could represent an unlikely ally for treating glioblastoma. This is very welcome news, as glioblastoma is the most common and aggressive kind of malignant brain tumour in adults.

This discovery was made by researchers at the University of Campinas’s School of Pharmaceutical Sciences (FCF-UNICAMP) in São Paulo State, Brazil.

Previous studies have shown increased mortality rates for human progenitor cells, as well as growth inhibition and morphological abnormalities, in cells infected with Zika Virus. This is likely the cause of the observed microcephaly cases. The virus has also been shown to be capable of moving into brain cells, modifying the regulation of the cell cycle, and inducing their death.

In light of these findings, the researchers at FCF-UNICAMP set out to investigate the effects of Zika virus when it infects glioblastoma cells. To do this, they infected human malignant glioblastoma cells with Zika and recorded microscope images of them 24 hours and 48 hours after infection in order to observe any metabolic alterations (cytopathic effects) caused by inoculation of the virus.

The results of the analysis showed that the glioblastoma cells displayed moderate cytopathic effects 24 hours after infection, such as rounded, swollen cell bodies and formation of syncytia, masses of cytoplasm in which the membrane contains several nuclei.

The most severe cytopathic effects were observed 48 hours after infection, with a larger number of rounded, swollen cells, more syn-

cytium formation and pronounced loss of cell integrity, all of which denote cell death.

To identify the main compounds (metabolites) produced by glioblastoma cells during infection by Zika, the researchers analyzed the cells using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI). The mass spectrometry data were submitted to statistical analysis, which showed that 24 hours after infection, the cells began to produce cardiac glycosides, especially digoxin.

Because digoxin and other cardiac glycosides have been shown to induce cancer cell death, the researchers concluded that infection by Zika triggered synthesis of the molecule in glioblastoma cells and that this phenomenon is probably one of the factors that lead to neuronal cell death. “Digoxin could be the key molecule that activates glioblastoma cell death during Zika infection,” said senior study investigator Rodrigo Ramos Catharino, Ph.D., a professor at FCF-UNICAMP and head of the institution’s Innovare Biomarker Laboratory.

Based on these findings, the researchers suggest that a genetically engineered Zika virus could eliminate the effects of infection and leave only the viral particles that synthesize digoxin.

By Disha Padmanabha

Vol. 02 NO 10

March 6th, 2018.

Microplastics Moving Up the Marine Food Chain Risking Ocean’s Top Predators Microplastics are highly bioavailable to marine organisms, either through direct ingestion, or indirectly by trophic transfer from contaminated prey. Now, for the first time, scientists have shown that microplastics within fish can transfer to marine predators at the top of the food chain, further risking the exposure of man-made chemicals to animals and – in the long run – us.

It’s no shocker of how little regard we have towards our fellow species. But this is just despicable; being such highly intellectual lifeforms, how to actually behave the part is clearly lost on us.

Over 400 million tons of plastic are produced globally each year. It is estimated that one third of all plastic waste ends up in soils or freshwaters.

Microplastics are synthetic and persistent particles that originate from a variety of sources, which include the fragmentation of larger macro-plastics (e.g. fishing gear, packaging) by UV photo-degradation, wave action and physical abrasion; shipping spills of pre-production pellets (nurdles) and polystyrene beads; the discharge of waste water containing microbeads used in cosmetics and microfibers released during the washing of textiles; and run-off from land containing road marking paint and vehicle tyre fragments. Their small size means that microplastics are bioavailable to ingestion by

a variety of taxa including zooplankton, marine invertebrates, fish, seabirds, and marine mammals.

And we all know the food cycle- little fish eats plankton, bigger fish eats the little fish, then a seal eats the bigger fish, thus consuming the energy from all three smaller animals.

Now, if this little fish was to seek and consume or even accidentally ingest an indigestible piece of plastic, it naturally ends up in the belly of a predator like the seal.

This process, known as trophic transfer, has for the first time, been demonstrated by researchers from Plymouth Marine Laboratory (PML), University of Exeter and the Cornish Seal Sanctuary.

“Our findings suggest that trophic transfer represents an indirect, yet potentially major, pathway of microplastic ingestion for any species whose feeding ecology involves the consumption of whole prey,” the authors write in the study.

Researchers analysed scat (faeces) from captive grey seals (Halichoerus grypus) and the digestive tracts of the wild-caught Atlantic mackerel (Scomber scombrus) the seals were fed upon. One third of the mackerel and half of the scat samples contained microplastics, a finding that demonstrates a process known as trophic transfer, whereby prey con-

taining microplastics are consumed by predators and the synthetic particles move up the food web as a result. This process has previously been observed in animals lower down the food chain, such as mussels and crabs, but this study is the first to provide evidence of it occurring in marine mammals.

Lead author Sarah Nelms of PML’s Microplastics Research Group commented: “Our finding that microplastics can be passed from fish to marine top predators is something we’ve long thought was the case but, until now, lacked the evidence to back our theory up. We have shown that trophic transfer is an indirect, yet potentially major, route of microplastic ingestion for these predators. By examining scat from captive animals and the digestive tracts of fish they were fed upon, we could eliminate the possibility that the seals were eating plastic directly and be sure that any microplastics we

found in their scat came via the fish” Dr Pennie Lindeque, lead of PML’s microplastics research, added: “Our study demonstrates how microplastics can be transferred from prey to predator and therefore passed up through the food chain. More work is needed to understand the extent to which microplastics are ingested by wild animals and what impacts they may have upon the animals and ecosystems.”

The new study highlights the importance of reliable, scientifically based data on degradation behaviour and the effects of microplastics. This data is necessary to be able to respond effectively to contamination by microplastics and the risk they pose to terrestrial ecosystems – where, after all, most plastic waste that enters the environment accumulates.

Common Skin Bacterium Could Offer Protection Against Cancer Mammalian skin harbors diverse microbial communities whose growth is influenced by ecological factors on the body surface such as humidity, temperature, pH, lipid content, and the presence of antimicrobials produced by the host. And this interplay of microbe and host appears is critical for establishing homeostasis but is poorly understood.

Coagulase-negative staphylococcal species, such as Staphylococcus epidermidis, Staphylococcus hominis, and others, are the predominant bacterial species that colonize normal human skin, whereas Staphylococcus aureus frequently colonizes abnormal skin such as that found in patients with atopic dermatitis.

Now, in the recent study, researchers University of California San Diego School of Medicine researchers report a potential new role for some of these bacteria on the skin: protecting against cancer.

“We have identified a strain of Staphylococcus epidermidis, common on healthy human skin, that exerts a selective ability to inhibit the growth of some cancers,” said Richard Gallo, MD, PhD, Distinguished Professor and chair of the Department of Dermatology at UC San Diego School of Medicine.

“This unique strain of skin bacteria produces a chemical that kills several types of cancer cells but does not appear to be toxic to normal cells.”

The finding was somewhat serendipitous.

With previous research showing that chemicals produced by Staphylococcus species commonly found on healthy human skin can kill off certain harmful bacteria, the team looked at numerous strains to explore their antimicrobial powers.

They were testing various strains of Staphylococcus from human skin, and found one that killed group A strep, which cause a range of pesky infections from strep throat to cellulitis. They can take on a flesh-eating form, causing necrotizing fasciitis, also.

Whatever it was that the staph bacteria made, it was not a protein — the usual product that cells make and secrete, they reported in the journal Science Advances.

Instead, it was a molecule called 6-N-hydroxyaminopurine (6-HAP for short). It interferes with DNA polymerase activity and slowed the proliferation of tumor cells.

Mice that received intravenous injections of 6-HAP every 48 hours over a two-week period experienced no apparent toxic effects, but

By Disha Padmanabha A strain of bacteria that commonly lives on the human skin produces 6-HAP that can kill cancer cells without harming other cells. About 20 percent of healthy humans have 6-HAP-producing Staphylococcus epidermidis. (Credit: UC San Diego Health)

when transplanted with melanoma cells, their tumor size was suppressed by more than 50 percent compared to controls.

“There is increasing evidence that the skin microbiome is an important element of human health. In fact, we previously reported that some bacteria on our skin produce antimicrobial peptides that defend against pathogenic bacteria such as, Staph aureus,” said Gallo.

Julian Marchesi, professor of human microbiome research at Cardiff University who

was not involved in the study, welcomed the findings. “[This research] further adds to a growing understanding of how important the human microbiota, and in this case the skin microbiome, is to health. We have evolved to need these microbes and desperately need to understand all the roles they play in human biology and start to think more about what it is to be a human being,” he told The Gaurdian. “The next stage of this exciting work, will be to translate it to human clinical trials and show that this bacterially produced chemical can protect the host from skin cancers.”

7

Vol. 02 NO 10

March 6th, 2018.

An Antidote for Arthritis : Scorpion Venom?!

Rheumatoid arthritis (RA) is an autoimmune disease in which the body’s immune system – which normally protects its health by attacking foreign substances like bacteria and viruses – mistakenly attacks the joints.

This creates inflammation that causes the tissue that lines the inside of joints (the synovium) to thicken, resulting in swelling and pain in and around the joints.

If the inflammation goes unchecked, it can damage cartilage, the elastic tissue that covers the ends of bones in a joint, as well as the bones themselves. Over time, there is loss of cartilage, and the joint spacing between bones can become smaller. Joints can become loose, unstable, painful and lose their mobility. Joint deformity also can occur, which is irreversible.

But these patients might eventually be cleared of the disease, thanks to a new study led by Dr. Christine Beeton at Baylor College of Medicine that has now determined that one component out of hundreds in scorpion venom can ease the symptoms of RA in animal models; there also weren’t side effects like

those seen with other treatments like this one.

“Rheumatoid arthritis is an autoimmune disease – one in which the immune system attacks its own body. In this case, it affects the joints,” said Beeton, associate professor of molecular physiology and biophysics and member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. “Cells called fibroblast-like synoviocytes (FLS) play a major role in the disease. As they grow and move from joint to joint, they secrete products that damage the joints and attract immune cells that cause inflammation and pain. As damage progresses, the joints become enlarged and are unable to move.”

Current treatments target the immune cells involved in the disease and none are specific for FLS. Beeton and her colleagues studied FLS looking for an ‘Achilles’ heel’ that would allow them to prevent or stop them from damaging the joints.

A Synthetic Molecule That Sabotages a Viruses’ Ploy for Infection Retinoic acid-inducible gene I (RIG-I) is an innate immune sensor that plays a key role in recognizing and responding to infection

by RNA viruses. The gene is activated under conditions that introduce a terminal, double-stranded RNA (dsRNA) molecule into the cell. These molecules can include viral genomes, replication intermediates, and any other species containing a stable RNA duplex that is terminated with a 5′-triphosphate or diphosphate group.

This activation eventually leads to a series of events involving a variety of antiviral effector functions. When appropriately delivered and modulated, RIG-I agonists would be promising tools for application in immuno-oncology, antiviral prophylaxis, and vaccine adjuvant development. However, all these applications require a specific and potent RIG-I ligand that is functional in vivo.

Therefore, through a new study, researchers at Yale have now developed a set of synthetic molecules that may help boost the strength of this key, virus-fighting protein. The Yale team, led by biologists Anna Pyle and Akiko Iwasaki, has designed molecules that jumpstart the process. These synthetic, stem-loop RNA (SLR) molecules can be visualized as short cords with a knot at one end. The configuration enables the SLRs to bind with RIG-I molecules in a way that prompts an aggressive response.

“When you tickle RIG-I with this small, RNA hairpin, it alerts the body that it’s time to respond,” said Pyle, professor of molecular, cellular, and developmental biology, and of chemistry, at Yale, and co-corresponding author of the study. “This gives us a tool that can help with everything from the design of better vaccines to better antivirals and anti-cancer therapies.”

Previous work by the team has suggested that RIG-I function can be controlled and exploited pharmacologically through stimulation with small, well-defined RNA ligands that are no larger than other therapeutically administered oligonucleotides.

Structural studies, quantitative biochemical work, cell-based assays, and imaging studies have all established that RIG-I is an “RNA end-capper” that encircles a 10–base pair (bp) RNA duplex as a monomer and forms a network of specific interactions with the terminal base pair and the 5′-triphosphate.

RIG-I binding to short dsRNA is sufficient to trigger MAVS activation, and this process is enhanced by K63-ubiquitin, which promotes multimerization of the RIG-I CARD domains. On longer dsRNA (>40 bp), RIG-I forms aggregated filaments in vitro, and signaling in cell culture is less dependent upon K63-ubiquitin. However, the study could not elucidate the RIG-I oligomerization requirement for in vivo signalling.

The new study represents the first time scientists have been able to specifically manipulate and analyze the RIG-I biosensor in a living animal — in this case, mice. The Yale researchers said further study is needed in order to gauge the potential for developing new drugs for everything from flu to various forms of cancer.

“In previous work, we identified a potassium channel on FLS of patients with rheumatoid arthritis and found that the channel was very important for the development of the disease,” Beeton said. “We wanted to find a way to block the channel to stop the cells damaging the joints.”

“Scorpion venom has hundreds of different components. One of the components in the venom of the scorpion called Buthus tamulus specifically blocks the potassium channel of FLS and not the channels in other cells such as those of the nervous system,” said first author Dr. Mark Tanner, a graduate student in the Beeton lab during the development of this project.

In this study, they investigated whether this venom component, called iberiotoxin,

would be able to specifically block the FLS potassium channel and reduce the severity of rheumatoid arthritis in rat models of the disease. They found that iberiotoxin stopped the progression of the disease. In some cases it reversed the signs of established disease, meaning that the animals had better joint mobility and less inflammation in their joints with no side effects.

Dr. Christine Beeton said, “Although these results are promising, much more research needs to be conducted before we can use scorpion venom components to treat rheumatoid arthritis.”

“We think that this venom component, iberiotoxin, can become the basis for developing a new treatment for rheumatoid arthritis in the future.”

SCIENTISTS DEVELOP LIQUID CURRENT-ASSISTED SELF-ASSEMBLING BIOPRINTING TECHNIQUE Effective integration of molecular self-assembly and additive manufacturing would provide a technological leap in bioprinting.

A collaborative team involving researchers from Queen Mary University of London, University of Oxford, and Nanyang Technological University in Singapore, has now designed a new molecular printing technique using cells and molecules normally found in natural tissues to create constructs that resemble biological structures.

These structures are embedded in an ink which is similar to their native environment and opens the possibility to make them behave as they would in the body.

“The technique opens the possibility to design and create biological scenarios like complex and specific cell environments, which can be used in different fields such as tissue engineering by creating constructs that resemble tissues or in vitro models that can be used to test drugs in a more efficient

manner,” explained Professor Alvaro Mata, from the university’s School of Engineering and Materials Science.

The novel technique integrates the microand macroscopic control of structural features that printing provides with the molecular and nano-scale control enabled by self-assembly.

Because of this, it addresses a major need in 3D printing where commonly used printing inks have limited capacity to actively stimulate the cells that are being printed.

PhD student Clara Hedegaard, leading author of the paper, added: “This method enables the possibility to build 3D structures by printing multiple types of biomolecules capable of assembling into well defined structures at multiple scales. Because of this, the self-assembling ink provides an opportunity to control the chemical and physical properties during and after printing, which can be tuned to stimulate cell behaviour.”

“I was shocked to see how potent this small RNA molecule is in stimulating antiviral interferon responses in mice. For its specificity and potency, we now use SLR for all of our RIG-I research in the lab,” said Iwasaki, professor of immunobiology and of molecular, cellular, and developmental biology, and co-corresponding author of the study.

By Disha Padmanabha

8

By Disha Padmanabha

By Disha Padmanabha

Vol. 02 NO 10

March 6th, 2018.

Brain-like “Memtransistor” takes Neuromorphic Computing to the Next Level Advances in machine learning have moved at a gallop in recent years, but the computer processors these programs run on have barely changed. Traditional CPUs process instructions based on “clocked time” – information is transmitted at regular intervals, as if managed by a metronome.

But now, a new cutting-edge approach is taking shape: “neuromorphic computing,” by packing in digital equivalents of neurons, neuromorphics communicate in parallel (and without the rigidity of clocked time) using “spikes” – bursts of electric current that can be sent whenever needed. Just like our own brains, the chip’s neurons communicate by processing incoming flows of electricity – each neuron able to determine from the incoming spike whether to send current out to the next neuron.

What makes this a big deal is that these chips require far less power to process AI al-

gorithms. Application of neuromorphic semiconductors could prove extremely useful in areas including pattern recognition on a massive scale.

Now, a new research has been able to realise this dream by building what is called the “memtransistor,” which is a multi-terminal device made from a single layer of the semiconductor molybdenum disulfide (MoS2).

The device operates much like a neuron by performing both memory and information processing. With combined characteristics of a memristor and transistor, the memtransistor also encompasses multiple terminals that operate more similarly to a neural network.

This most recent research builds on work that Mark C. Hersam, the co-author of the present study and his team conducted back in 2015 in which the researchers developed a three-terminal, gate-tunable memristor that operated like a kind of synapse.

Human Placenta Stem Cells Found to Engender Two Different Types of Cells Vascularization is an essential physiological process that occurs during embryonic and fetal development and in disease. It is well documented that endothelial cells arise from precursors of the splanchnopleural or paraxial mesoderm. They are also expected to also derive from mesodermal progenitors devoid of hematopoietic potential.

The new stem cells are related to endothelial cells, which are used to create new blood vessels, and mesenchymal stem cells, which form bone, fat, cartilage and muscle. And now, scientists at the University of Queensland have discovered a new type of stem cell which has the potential to perform two functions at the same time, meaning better treatment or even cures for many diseases.

“In the past, each of these stem cell would have been harvested and spun together and then given to the patient,” UQ Centre for Clinical Research’s Dr Abbas Shafiee said.

“Now it is just a dual cell, which means the cell has two specific functions at the same time.”

“We first thought it was a mistake and our

isolation process was not pure enough and somehow our endothelial cells were getting contaminated by mesenchymal cells,” Kiarash Khosrotehrani, corresponding author of the study, told New Atlas. “But despite our best efforts in cleaning up the isolation we noticed that some endothelial progenitors were also giving rise to mesenchymal cells.

Finally to have definitive proof that this was not contamination, we isolated and observed placental cells one by one. In this single cell environment there is no contamination.”

Professor Khosrotehrani said the dual cells meant arteries and veins could be created in engineered tissue to provide more effective treatments for a range of musculoskeletal and degenerative disorders such as pulmonary fibrosis and heart disease.

The researchers were able to precisely locate stem cells in placental tissue and determine exactly how the stem cells worked to produce the lining of blood vessels and surrounding cells. Dr Shafiee said this regenerative process was the key to taking the next step in stem cell treatment, but more research was needed to better understand the biology of placental stem cells.

By Disha Padmanabha

While this work was recognized as mimicking the low-power computing of the human brain, critics didn’t really believe that it was acting like a neuron since it could only transmit a signal from one artificial neuron to another. This was far short of a human brain that is capable of making tens of thousands of such connections.

“Traditional memristors are two-terminal devices, whereas our memtransistors combine the non-volatility of a two-terminal memristor with the gate-tunability of a three-terminal transistor,” said Hersam to IEEE Spectrum. “Our device design accommodates additional terminals, which mimic the multiple synapses in neurons.”

Atomically thin MoS2 with well-defined grain boundaries influence the flow of current. Similar to the way fibers are arranged in wood, atoms are arranged into ordered domains — called “grains” — within a material. When a large voltage is applied, the grain boundaries facilitate atomic motion, causing a change in resistance.

“Because molybdenum disulfide is atomically thin, it is easily influenced by applied electric fields. This property allows us to make a transistor. The memristor characteristics come from the fact that the defects in the material are relatively mobile, especially in

the presence of grain boundaries,” Hersam explained.

“When the length of the device is larger than the individual grain size, you are guaranteed to have grain boundaries in every device across the wafer. Thus, we see reproducible, gate-tunable memristive responses across large arrays of devices.”

“This is even more similar to neurons in the brain,” Hersam said, “because in the brain, we don’t usually have one neuron connected to only one other neuron. Instead, one neuron is connected to multiple other neurons to form a network. Our device structure allows multiple contacts, which is similar to the multiple synapses in neurons.”

Next, Hersam and his team are working to make the memtransistor faster and smaller.

Hersam also plans to continue scaling up the device for manufacturing purposes.

“We believe that the memtransistor can be a foundational circuit element for new forms of neuromorphic computing,” he said. “However, making dozens of devices, as we have done in our paper, is different than making a billion, which is done with conventional transistor technology today. Thus far, we do not see any fundamental barriers that will prevent further scale up of our approach.”

HUMANS ARE EVOLVING TO RESENT ALCOHOL: STUDY It is a common misunderstanding that evolution took place a long time ago, and that to understand ourselves we must look back to the hunter-gatherer days of humans. Fact check- we are not only evolving, we are doing so even faster than before.

When we look at how evolution has taken us from eyeless blobs to moderately capable bloggers, it can seem like a vast, unknowable force. But when we look at individual traits and how they appear and disappear in clever ways, the functioning of cause and effect is clear, and fascinating, to see.

Now, in a latest study, researchers have found proof that suggests people have begun evolving so as to find alcohol so unpleasant, it could stop our species from drinking in the future.

Researchers at the University of Pennsylvania analyzed the genomes of some 2,500 people from 26 populations across four continents using data collected by the 1,000 Genomes Project.

The team then singled out specific traits or “genomic hotspots” that pop up in various, divergent populations – say, changes to an area of the gene responsible for producing glycophorins, which has occurred in parts of Africa and Asia.

They were able to identify five ‘hot spots’ of recent genetic change, one of them associated with the alcohol dehydrogenase (ADH) gene, which breaks down alcohol. The ADH gene is responsible for inducing production of alcohol dehydrogenase, an enzyme that breaks down alcohol into acetaldehyde, which is then converted to acetate by another process.

Therefore, even the smallest amount of alcohol would cause extremely unwell feelings and it is unlikely these individuals would be able to physically consume enough alcohol for them to develop alcoholism.

Interestingly, the genetic variations were not just found in one population but were observed in five populations in different continents, for this to have happened, the mutation must have emerged independently in these two different populations and persisted. Alternatively, if there had been just one initial mutation, it would have had to travel like Speedy Gonzales across the two continents.

“These new results are critically important to our understanding of how alcohol affects heart disease. Contrary to what earlier reports have shown, it now appears that any exposure to alcohol has a negative impact upon heart health,” says co-lead author Michael Holmes, MD, PhD, research assistant professor in the department of Transplant Surgery at the Perelman School of Medicine at the University of Pennsylvania. “For some time, observational studies have suggested that only heavy drinking was detrimental to cardiovascular health, and that light consumption may actually be beneficial. This has led some people to drink moderately based on the belief that it would lower their risk of heart disease. However, what we’re seeing with this new study, which uses an investigative approach similar to a randomized clinical trial, is that reduced consumption of alcohol, even for light-to-moderate drinkers, may lead to improved cardiovascular health.”

By Disha Padmanabha

9

Vol. 02 NO 10

March 6th, 2018.

PhD ADMISSIONS lied subject with a minimum of 55% marks or equivalent Letter-grade/Grade-point under the seven Point Letter-grade-scales as laid down by the UGC. A relaxation of 5% in minimum marks shall be given to SC/ST andphysically handicapped/disabled candidates. Candidates appearing for Final Year/ Final Semester of their postgraduate degree examination are also eligible to appear for the admission process subject to the fulfillment of minimum eligibility criteria in the final result at the time of counseling.

PhD Admissions 2018 @ Dr. Ram Manohar Lohia Avadh University, Faizabad PhD Admissions 2018 @ Dr. Ram Manohar Lohia Avadh University, Faizabad. Dr. Ram Manohar Lohia Avadh University Admission Notification 2018.

Dr. Ram Manohar Lohia Avadh University, Faizabad hereby commences the process of admission to full-time Ph.D. program in various subjects (as per University Rules), run by the residential departments and affiliated colleges.

Overall admission process for Ph.D. programs of Dr. Ram Manohar Lohia Avadh University,Faizabad is divided in following two phases:Phase-1 :- Candidate has to appear in a Common Entrance Test (CET-2018) that will be conducted by the University for the session 2018. Candidates who had qualified NET/JRF/GATE examinations or laying under any of the category mentioned in UGC norms shall be exempted to appear in CET2018 and shall be allowed to appear directly in the second phase of the admission process but strictly required to apply on-line in phase 1 to participate in the second phase of admission process. If candidate fails to apply online, he/she will not be considered to participate in the admission process for various PhD programs of Dr. Ram Manohar Lohia Avadh University, Faizabad.

Phase-2 :- Candidates, declared eligible after CET-2018 are participate in the second phase will be invited to appear in the Interview on the basis of CET merit or, in accordance of UGC guidelines. Research Development Committee (RDC)/ Equivalent Committee will conduct the interview of invited eligible candidates and prepare final merit for admission.

Syllabus : Syllabus of CET-2018 of Dr. Ram Manohar Lohia Avadh University will be similar to that is prescribed for NET/JRF Examinations of University Grants Commissions (UGC), Council of Scientific and Industrial Research (CSIR), Indian Council of Agricultural Research (ICAR) which may be seen from their respective website.

Eligibility : A candidate applying for CET-2018 of Dr. Ram Manohar Lohia Avadh Universitymust hold a postgraduate Degree in concerned/al-

10

Guidelines for Entrance Test: a. The CET-2018 for various PhD programs of Dr. Ram Manohar Lohia Avadh University as specified in Table-A, will be conducted at the University Campus but in special circumstances Centers may also be allocated at different institutions in Faizabad district. b. Candidates are advised to fill up the Answer-OMR sheet carefully during Examination. c. The Eligibility Test will be based on Multiple Choice Questions (MCQs) containing two question papers: First Paper – The Paper will be of 100 marks comprising of 100 questions to assess general awareness, academic aptitude and subject proficiency. This paper will be of 2 hours duration.

Second Paper – The paper will be of 200 marks comprising of 200 questions to assessubject expertise, research aptitude & subject knowledge. This paper will be of 3 hours duration. d. There will not be any negative marking. e. The minimum qualifying marks for the test is 50 percent marks on the aggregate but minimum 40 percent marks required separately in each paper. f. A relaxation of 5 percent in qualifying marks (in the aggregate and in each paper as well) will be provided to the candidates belonging to the SC/ST/PH categories. g. The average percentage of marks will not be rounded off to the next higher integer. h. Black Ball Point Pen should be used for blackening the circles on the answer sheet. i. Correction fluid should not be used. j. Candidates are not permitted to carry in the examination Hall/Room paper, mobile phone or any other type of gadget for communication. k. Nothing should be written on the Question Booklet except Roll Number. l. The candidates should ensure that the answer sheet is not folded or damaged and there are no stray marks on the answer sheet. m. The candidate must bring his/her admit card in order to appear in CET-2018. If a candidate fails to bring the admit card he/she will not be allowed to appear in the CET2018. n. The Duration of the Examination will be two hours for first paper and three hours for second paper. o. Based on the marks obtained in this entrance test, category wise merit list will be prepared and the category wise result of the successful candidates will be displayed on the website of the university. p. A category wise Merit Score Certificate will be issued and dispatched to the candidate by Speed/Registered Post and to his/her e-mail address, if provided.

How to Apply:

•

On-line Application Procedure :

•

Candidate may fill on-line application form for PhD admission process/CET-2018 of Dr. Ram Manohar Lohia Avadh University through the University website www.rmlau. ac.in. During on-line application form filling process candidate has to upload scanned copies of his passport size photograph and signature.

•

Last date for submission of online application form-13/04/18 Date of downloading admit cards-05/05/18 Date of Common Entrance Test (CET2018).-12/05/18

Registration Fee for On-line Application : Registration fee for the online application to CET2018 of Dr. Ram Manohar Lohia Avadh University is Rs. 1000/- for General and OBC candidates whereas for SC/ST candidates it is Rs. 500/-. Bank transaction charges will be charged as applicable.

Registration fee for Online Application to PhD admission process/CET-2018 of Dr. Ram Manohar Lohia Avadh University can be submitted online through Net-Banking or Debit/Credit-Card of any nationalized bank.

Applicants are advised to note down bank transaction Reference Number and Registration ID for any future communication with the University. After the fee submission, applicants will be redirected to the University website where options for printing admission form and fee receipt are given. Printout of the pay-inslip of SBI along with the print out of the application form is to be taken by the applicant.

University reserves the right to seize admission in Ph.D. program in any subject at any time subjected to the unavailability of Supervisors. Similarly, number of admission seats in Ph.D. program in any subject at any time may also be increased or decreased in view of the supervisor’s availability.

The candidate is solely responsible for all the entries made by him/her in the on-line application form. If the candidate conceals or misrepresents any fact in the entries on the form, his/her candidature will automatically stand cancelled and he/she will be liable to be debarred from the present and future admissions in the University.

Entries made by the candidate in the Form will be considered final, and no subsequent request for change(s) or modification(s) in the same will be entertained.

Documents required at the time of Admission for PhD courses.

• • • • • • • • • •

High School Certificate (As age proof) High School Mark sheet Intermediate Mark sheet & Certificate under Graduate Mark sheet & Degree Post Graduate Mark sheet & Degree Caste Certificate (if applicable) UGC NET Certificate (if applicable) Fellowship certificate of UGC/CSIR/ ICAR or other central regulatory Bodies. (If applicable) ‘No Objection Certificate’ from present employer, if employed Any other relevant certificate

Important Dates: • •

Availability of online application form for PhD admission process – 26/02/18 Last date for submission of online application fees -10/04/18

PhD Programme Admissions (2018-19) @ NISER PhD Admissions at NISER, School of Biological Sciences. NISER has announced Admissions for PhD Programme 2018-19.

Applications are invited from Indian citizens for admission to Ph.D Programme scheduled to commence from 27th July, 2018 in the following schools of basic sciences at NISER, Bhubaneswar: 1. School of Biological Sciences (SBS) 2. School of Chemical Sciences (SCS) 3. School of Physical Sciences (SPS) 4. School of Mathematical Sciences (SMS) 5. School of Humanities and Social Sciences (SHSS) Stream : Biological Sciences# Minimum Educational Qualifications: 60% or equivalent GPA in Masters or M. Tech in any branches of Biology, Life Sciences, Pharmaceutical Sciences, Agricultural Sciences, Veterinary Sciences, Computer Sciences, Bioinformatics and Biotechnology. Students with Master’s degree in Physics, Chemistry or Mathematics having interest in pursuing a career in Biology are also encouraged to apply. # Research areas in School of Biological Sciences: • • • • • •

Regulation of cell adhesion and signaling in Helicobacter pylori-mediated gastric cancer progression.

Study of membrane biogenesis: Mechanism and regulation of nuclear remodeling and role of dynamins Regulation of cell structure and functions by thermosensitive TRP ion channels Molecular Genetics and Epigenetics of Ageing Disorders: Neurodegeneration and Cancer Antibiotic resistance and virulence: Focus on membrane proteins and persistence phenomenon Interaction of light and auxin in shaping development in plants; Role of splice variant of constsns, CO like and

Vol. 02 NO 10

• • • • • •

GIGANTEA in the regulation of Florigen Molecular Genetics of Gallbladder cancer; putative angiogenic regulators and tumorigenesis Neuro endorcrine regulation, Neural circuitry of energy balance and reproduction Translational Control Structure-and-function work on two component systems/transporters Regulation of cell and tissue morphology Organisation of cytoskeleton by molecular motors in extant eukaryotes: dictyostelium and tetrahymena;Mitotic apparatus in Bacterial systems

Student intake in these advertised areas will depend on the availability of seats with individual PIs. 2. Candidates should have qualified at least one of these national level examinations i.e.

CSIR-UGCNET/GATE/GPAT/JEST/INSPIRE (Doctoral fellowship under AORC Scheme)/JGEEBILS/NBHM (with fellowship) or any other equivalent national level

March 6th, 2018. examination, valid for the current year in the relevant area of research.

3. The scholarship given by NISER is Rs. 25,000/- for first two years, which vvill subsequently be enhanced to Rs. 28,000/- for remaining three years, subject to the condition that he/she fulfills all the requirements of the Institute that will be stipulated from time to time.

4. Candidates who are appearing in the final semester/year of qualifying examination in 2018 are also eligible to apply. However, they should have scored minimum 60% or equivalent grade till the end of the third semester / relevant year as the case may be_ If selected, their admission will be subject to submission of final semester / year res ult mark sheet wherein they should have obtained the requisite percentage / grade as mentioned @ Para 1.

Selection Procedure: • The selection committee of the respective schools will short-list the candidates among those who meet the minimum educational qualifications and satisfy additional criteria

which each school may set as deemed necessary.

• The short-listed candidates will be called for an interview, supplemented by a written test, if necessary, for the admission.

• Based on the academic record and the performance of the candidates in the selection process, the selection committee of the school will recommend candidates to the Chairman, Academic Council for admission to the Ph.D. program.

• All candidates called for the Test I Interview will be paid to and fro single, second­ sleeper class railway fare by the shortest route from their place of residence to the Institute/ venue of the Test and Interview. They have to produce evidence (railway ticket) in support of their claim.

How to Apply: • The application form has to be filled up online at http://www.niser.ac.in and candidates should follow stepwise instructions mentioned to complete the application submission process. At the time of application, along with this online form, the candidate

should upload soft copy of the supporting documents as per the eligibility criteria.

• Candidates intending to apply for more than one school should fill up online application forms for each school and submit separate forms with appropriate supporting documents.

• Two sealed letters of reference in the prescribed format with signature of the referee on the envelope should be produced by the student at the time of interview. The copy of the reference letter is available on line.

• NISER does not demand any application fee from the candidates who apply for Ph.D program.

Important Dates: • • • •

Online application will be activated on : 26.02.2018 Last date for filling up online application : 26/03/2018 List of short-listed candidates will be uploaded on NISER website latest by School of Biological Sciences : 06.04.2018

JOBS KARNATAKA GOVT RECRUITMENT : 18 POSTS OF SCIENTIFIC OFFICER VACANT Karnataka State Police Recruitment.

KSP Recruitment 2018. Karnataka Govt Jobs. Karanataka Govt Forensic Sciences Lab Jobs. Scientific Officer Posts.

RECRUITMENT TO THE POST OF SCIENTIFIC OFFICERS (FSL) BANGALOREAPPLICATION FOR THE POST OF SCIENTIFIC OFFICERS (MEN & WOMEN) IN FSL, BENGALURU AND ITS REGIONAL OFFICE- 2018 Notification No.69 /Recruitment-2/2017 -18 Name of the Position : Scientific Officer No.of.Positions : 18 Age : Minimum Age of 21 years and maximum age of 35 years (Age relaxation in maximum age by 3 years for OBC and 5 years for SC/

ST) Fee Details : GM & OBC (2A,2B,3A,3B) : Rs. 250 SC , ST, CAT-01 : Rs. 100 Education Qualifications: Section 1 Scientific Officer in Chemical Section: Must be a holder of Master’s Degree in Chemistry / pharmacology / Bio-Chemistry / Forensic Science / Equivalent qualification in Chemical science with at least 55% aggregate marks.

Section 2 Scientific Officer in Biology Section: Must be a holder of Master’s Degree in Botany / Zoology / Bio-Chemistry / Microbiology / Life Sciences / Forensic Science or Equiva-

lent qualification in Bio-science with at least 55% aggregate marks.

Section 3 Scientific Officer in Toxicology Section : Must be a holder of Master’s Degree in Chemistry / pharmacology / Bio-Chemistry / Forensic Science / Equivalent qualification in Chemical secience with atleast 55% agreegate marks.

Common for Above Qualifications : Must have not less than two years research experience as a research scholar in any research institution recognized by the Government.

How to Apply:

BANK BRANCHES Candidates have to fill the Application and Generate the Challan and make the Payment in the respective Bank / Post office.

If Candidates submit more than one Application for the same Post, only one Application (finally submitted) will be considered.

If the candidate wants to apply more than one section, candidate should select according to priority.

Important Dates: • • •

DATE OF COMMENCEMENT OF FILLING OF THE ONLINE APPLICATION - 26/02/2018 LAST DATE FOR ONLINE APPLICATION GENERATION 21/03/2018 LAST DATE FOR PAYMENT OF FEE - 23/03/2018

NOTE : Payment should be made in State Bank of India (SBI) / Post office only.LIST OF SBI

11

Vol. 02 NO 10

March 6th, 2018.

KERALA AGRICULTURAL UNIVERSITY RECRUITMENT 2018 – MSC BIOTECH & BOTANY ELIGIBLE Kerala Agricultural University Recruitment 2018. Jobs at KAU. Senior Research Fellow Position vacant at KAU. Job Title : Senior Research Fellow (SRF) No.of.Posts : 01 Essential Qualification : Master’s Degree in Agriculture/ Biotechnology/Botany/ Integrated B.Sc – M.Sc Degree in Climate change Adaptation.

Age Limit : 4. Age of the applicant should not be below 18 years and above 36 years as on 01.01.2018 Age relaxation as per existing Government Rules will granted to eligible candidates.

Consolidated Pay : RS.25000/ per month.

How to Apply: Candidates with following minimum qual-

ifications are invited for a walk in interview on 14/03/2018 at 9.00 Am at KCAET, Tavanur. The selection is for a period of One year on contract basis.The details are given below: • Candidates should prepare their biodate in the format enclosed as Annexure – I and submit at the time of verification of certificates.

• 5. Candidates should report before the undersigned for interview at 9.00 AM on 14/03/2018 with their certificates and mark lists to prove educational

•

qualification, experience, age, date of birth, Religion, and caste.

No TA/DA will be paid to the candidates for attending interview. Candidates reporting after the sheduled time will not be permitted to attend the interview.

Walk-In Details: • Date of Interview – 14/03/2018 • Time of Interview – 09:00 AM • Venue of Interview – KCAET, Tavanur

TRAINING & RESEARCH POSTS VACANT @ NIT ROURKELA | BIOTECH & BIOINFORMATICS ELIGIBLE NIT Rourkela invites students pursuing Biotechnology & Bioinfromatics, to apply for Studentship positions at NIT Rourkela as per the details given below: Job Title : Trainee ship No.of.Posts : 02

Essential Qualification : Post Graduate degree in Biotechnology, Bioinformatics /Computer Science/Analytics Decision Sciences /Information Technology or allied subjects.

Desirable Qualification :

Project Title : “Bioinformatics Infrastructure Facility”

Sound knowledge in Bioinformatics or Computer languages.

Principal Investigator : Prof. M.K.Gupta

How to Apply:

Emoluments : Rs.8000.0

Eligible persons should bring all the origi-

12

nal certificates and mark sheets, filled application form in the prescribed format (available in the Institute Website) affixed with colored photographs to be submitted in duplicate along with photo copies of relevant certificates, grade/ mark sheets, publications etc.. at the time of walk-in-interview.

For technical information on the project, the candidate may contact the Principal Investigator at the following address: Name: Prof. M.K.Gupta Address: Department of Biotechnology & Medical Science, National

Institute of Technology (NIT), Rourkela-769 008.

Telephone No: +91-661-246-2294 (office) E-mail: guptam@nitrkl.ac.in Walk-In Details: • Date of Interview – 7th March, 2018 • Time of Interview – 10.00 am.

• Venue of Interview – Department of Biotechnology & Medical Science, NIT Rourkela.